These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

279 related items for PubMed ID: 5019377

  • 1. [Clinical trial of the therapeutic effect of Amantadine-HCL in Parkinson's Disease].
    Hacohen H, Gurtner B.
    Schweiz Med Wochenschr; 1972 Apr 22; 102(16):583-6. PubMed ID: 5019377
    [No Abstract] [Full Text] [Related]

  • 2. Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease.
    Schwab RS, England AC.
    Trans Am Neurol Assoc; 1969 Apr 22; 94():85-90. PubMed ID: 4907453
    [No Abstract] [Full Text] [Related]

  • 3. [Treatment of Parkinson's disease with amantadine].
    Sigwald J, Raymondeaud C, Grégoire J.
    Therapeutique; 1972 Nov 22; 48(9):555-60. PubMed ID: 4568230
    [No Abstract] [Full Text] [Related]

  • 4. [Amantadine. Prolonged clinical trial in 50 parkinsonian patients].
    Castaigne P, Laplane D, Dordain G.
    Nouv Presse Med; 1972 Feb 19; 1(8):533-6. PubMed ID: 5012351
    [No Abstract] [Full Text] [Related]

  • 5. L-dopa and amantadine hydrochloride in Parkinson's disease.
    Parkes JD, Zilkha KJ, Knill-Jones RP, Clements PJ, Baxter R.
    Int Z Klin Pharmakol Ther Toxikol; 1971 Apr 19; 4(3):356-60. PubMed ID: 4931417
    [No Abstract] [Full Text] [Related]

  • 6. [Results of two new drugs in Parkinson's disease: L-dopa and amantadine].
    Sigwald J, Raymondeaud C, Piot C.
    Rev Neurol (Paris); 1970 Feb 19; 122(2):145-8. PubMed ID: 4931718
    [No Abstract] [Full Text] [Related]

  • 7. [Amantadine hydrochloride in the treatment of Parkinson's syndrome].
    De la Herrán J, Figuerido JA.
    Rev Esp Otoneurooftalmol Neurocir; 1971 Feb 19; 29(167):45-9. PubMed ID: 5091472
    [No Abstract] [Full Text] [Related]

  • 8. Amantadine in the treatment of Parkinson's disease.
    Schwab RS, England AC, Poskanzer DC, Young RR.
    JAMA; 1969 May 19; 208(7):1168-70. PubMed ID: 5818715
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Parkinson's disease and amantadine hydrochloride.
    JAMA; 1969 May 19; 208(7):1180-1. PubMed ID: 5818720
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Combination of amantadine and levodopa in the treatment of Parkinson's disease. Indications. Results. Study of 58 cases].
    Sigwald J, Raymondeaud C.
    Nouv Presse Med; 1972 Apr 29; 1(18):1237-9. PubMed ID: 5025538
    [No Abstract] [Full Text] [Related]

  • 16. [Amantadine in the treatment of Parkinson's disease].
    Giombini S, Solero CL, Bazzan A, Ferrari P, Robotti E.
    Fracastoro; 1970 Apr 29; 63(6):869-81. PubMed ID: 5519639
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. L-dopa and amantadine in the therapy of parkinsonism.
    Weeth JB, Shealy CN, Mercier DA.
    Wis Med J; 1969 Nov 29; 68(11):325-8. PubMed ID: 4901055
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.